Prognostic Utility of Lipoprotein-Associated Phospholipase A ₂ for Cardiovascular Outcomes in Patients With Stable Coronary Artery Disease

This publication has 26 references indexed in Scilit:

• Local Production of Lipoprotein-Associated Phospholipase A ₂ and Lysophosphatidylcholine in the Coronary Circulation
  Circulation, 2007
• Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients
  European Heart Journal, 2007
• Lipoprotein-Associated Phospholipase A ₂
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
• High Lipoprotein-Associated Phospholipase A2 Is a Risk Factor for Recurrent Coronary Events in Postinfarction Patients
  Clinical Chemistry, 2006
• Lipoprotein‐Associated Phospholipase A₂: Review and Recommendation of a Clinical Cut Point for Adults
  Preventive Cardiology, 2006
• Lipoprotein-Associated Phospholipase A2 and Measures of Extracoronary Atherosclerosis
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
• Association between Lp-PLA2 and coronary artery disease: Focus on its relationship with lipoproteins and markers of inflammation and hemostasis
  Atherosclerosis, 2005
• Platelet-Activating Factor Acetylhydrolase Activity Indicates Angiographic Coronary Artery Disease Independently of Systemic Inflammation and Other Risk Factors
  Circulation, 2005
• Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery Disease
  New England Journal of Medicine, 2004
• Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis
  Journal of Lipid Research, 2003